BLOOD TEST MAY HELP PREDICT RISK OF COGNITIVE DECLINE DUE TO ALZHEIMER'S A DECADE BEFORE SYMPTOMS APPEAR

Summary

A blood test measuring p-tau217 levels can predict cognitive impairment risk in asymptomatic older adults with up to 78% accuracy a decade before symptom onset. The biomarker provides prognostic information beyond conventional brain imaging and genetic testing.